| CMR T1 Mapping for Diagnosis of Cardiac Amyloidosis (NCT04862273) | University of Leipzig | 2021-04-01 |
| Predictors of Left Ventricular Hypertrophy in Hypertensive Patients in Assiut Governorate (NCT03482934) | Assiut University | 2019-10-01 |
| Towards Understanding the Phenotype of Cardiovascular Disease in CKD - TRUE-Type-CKD Study (NCT03749551) | Johann Wolfgang Goethe University Hospital | 2018-03-28 |
| Early Valve Replacement Guided by Biomarkers of LV Decompensation in Asymptomatic Patients With Severe AS (NCT03094143) | University of Edinburgh | 2017-07-21 |
| Effects of a Reduction in Renal Function on Cardiovascular Structure and Function (NCT02973607) | University Hospital Birmingham NHS Foundation Trust | 2017-05-23 |
| Efficacy and Safety of Valsartan and Nebivolol/Valsartan in Hypertensive Patients With LVH (NCT03180593) | Trinity Hypertension & Metabolic Research Institute | 2017-02-07 |
| Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants (NCT03415750) | Edoardo Melilli | 2016-11-01 |
| Assessment of Efficacy of Mirabegron, a New beta3-adrenergic Receptor in the Prevention of Heart Failure (NCT02599480) | Jean-Luc Balligand | 2016-09-12 |
| EMPower: Electronic Media Powering Positive Health Changes in Youth (NCT02444689) | Johns Hopkins University | 2015-07-01 |
| Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension? (NCT02237339) | University of Dundee | 2014-09-01 |
| New-onset Diabetes and Left Ventricular Hypertrophy in Renal Transplantation (NCT01976689) | Baskent University | 2012-03-01 |
| Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy (NCT00989508) | University Hospital Birmingham | 2009-10-01 |
| The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5 (NCT00616902) | Abbott | 2009-01-01 |
| Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant (NCT00552851) | University of Wuerzburg | 2006-06-01 |
| Glutamate and Diastolic Function in Patients Undergoing Aortic Valve Repair (NCT01144039) | Medical University of Vienna | 2006-02-01 |
| The CLEVER Study - Coreg And Left Ventricular Mass Regression (NCT00108082) | GlaxoSmithKline | 2005-01-01 |
| Cardiac MR of Subclinical CVD: Impact of Age (NCT00041418) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-09-01 |
| The SILVER Study: Systolic Hypertension Interaction With Left Ventricular Remodeling (NCT00045994) | Synvista Therapeutics, Inc | 2001-08-01 |
| Racial Differences in the Coronary Microcirculation (NCT00005373) | National Heart, Lung, and Blood Institute (NHLBI) | 1992-09-01 |